XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS        
Total operating revenues $ 1,965 $ 4,528 $ 11,215 $ 12,826
Operating expenses:        
Cost of production 2,544 2,480 8,554 8,836
Depreciation and amortization 3,494 4,994 12,222 14,323
Research and development expense 1,113 1,558 4,302 4,716
General and administrative expense 11,679 10,522 35,342 31,891
Project development costs 6,593 4,789 19,648 10,635
Facility idling costs 550 911 2,325 2,923
Total operating expenses 25,973 25,254 82,393 73,324
Loss from operations (24,008) (20,726) (71,178) (60,498)
Other income (expense)        
Interest expense (1,107) (540) (2,762) (1,615)
Interest and investment income 3,843 5,261 12,579 14,083
Other income, net 116 305 328 292
Total other income, net 2,852 5,026 10,145 12,760
Net loss $ (21,156) $ (15,700) $ (61,033) $ (47,738)
Net loss per share - basic (in dollars per share) $ (0.09) $ (0.07) $ (0.25) $ (0.20)
Net loss per share - diluted (in dollars per share) $ (0.09) $ (0.07) $ (0.25) $ (0.20)
Weighted-average number of common shares outstanding - basic (in shares) 239,445,900 239,537,811 239,767,047 238,100,986
Weighted-average number of common shares outstanding - diluted (in shares) 239,445,900 239,537,811 239,767,047 238,100,986